fingolimod hydrochloride has been researched along with Granuloma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryan, AM; Del Poeta, M; Lazzarini, C; McQuiston, T; Nuesslein-Hildesheim, B; Qiu, Z; Sheridan, B; You, JK | 1 |
1 other study(ies) available for fingolimod hydrochloride and Granuloma
| Article | Year |
|---|---|
FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages.
Topics: Animals; Cell Line; Cryptococcosis; Cryptococcus neoformans; Female; Fingolimod Hydrochloride; Granuloma; Humans; Macrophages, Peritoneal; Male; Mice; Sphingosine-1-Phosphate Receptors | 2020 |